AVROBIO Inc. (AVRO) Financial Statements (2024 and earlier)

Company Profile

Business Address 490 ARSENAL WAY
WATERTOWN, MA 02472
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments90,48198,020105,842124,68972,32692,563
Cash and cash equivalents90,48198,020105,842124,68972,32692,563
Restricted cash and investments 283283283283 283
Prepaid expense 4118161,22132515999
Asset, held-for-sale, not part of disposal group   185   
Other current assets 6265708057928451,008
Other undisclosed current assets375728343,0473,5655,105
Total current assets:91,838100,261109,170128,84377,25199,958
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization      
Operating lease, right-of-use asset1104329122,2672,8571,057
Property, plant and equipment 2,2852,2852,2852,5742,894
Restricted cash and investments400400400400283 
Other noncurrent assets  40404040
Other undisclosed noncurrent assets  (2,285)(2,285)   
Total noncurrent assets:5108321,3524,9925,7543,991
TOTAL ASSETS:92,348101,093110,522133,83583,005103,949
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3,2855,4765,9129,41411,67212,116
Accounts payable243279101,071591384
Accrued liabilities3,0425,4495,0028,34311,08111,732
Other undisclosed accounts payable and accrued liabilities      
Debt      
Other undisclosed current liabilities2248781,6472,2502,627999
Total current liabilities:3,5096,3547,55911,66414,29913,115
Noncurrent Liabilities
Long-term debt and lease obligation    15,35615,276
Long-term debt, excluding current maturities     15,35615,276
Finance lease, liability      
Liabilities, other than long-term debt  105134352188
Operating lease, liability  105134352188
Total noncurrent liabilities:  10513415,70815,464
Total liabilities:3,5096,3547,66411,79830,00728,579
Equity
Equity, attributable to parent88,83994,739102,858122,03752,99875,370
Common stock444444
Additional paid in capital572,918572,010571,344568,946567,383564,798
Accumulated other comprehensive loss      
Accumulated deficit(484,083)(477,275)(468,490)(446,913)(514,389)(489,432)
Total equity:88,83994,739102,858122,03752,99875,370
TOTAL LIABILITIES AND EQUITY:92,348101,093110,522133,83583,005103,949

Income Statement (P&L) ($ in thousands)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
Revenues  7723232323
Sublease income   232323 
Gross profit:   232323 
Operating expenses(7,941)(9,627)(21,091)(15,729)(25,220)(25,257)
Other undisclosed operating income (loss)  (35)(1,865)83,713(23) 
Operating income (loss):(7,941)(9,662)(22,933)68,007(25,220)(25,257)
Nonoperating income (expense)1,1331,2541,356(531)263223
Investment income, nonoperating1,1461,2601,407(495)248245
Interest and debt expense 1,003 (1,367)(803) 
Other undisclosed loss from continuing operations before equity method investments, income taxes      (1,861)
Income (loss) from continuing operations before income taxes:(6,808)(7,405)(21,577)66,109(25,760)(26,895)
Other undisclosed loss from continuing operations  (377)    
Income (loss) from continuing operations:(6,808)(7,782)(21,577)66,109(25,760)(26,895)
Other undisclosed net income (loss)  (1,003)  8031,861
Net income (loss):(6,808)(8,785)(21,577)66,109(24,957)(25,034)
Other undisclosed net income attributable to parent   1,367  
Net income (loss) available to common stockholders, diluted:(6,808)(8,785)(21,577)67,476(24,957)(25,034)

Comprehensive Income ($ in thousands)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
Net income (loss):(6,808)(8,785)(21,577)66,109(24,957)(25,034)
Other comprehensive loss      
Comprehensive income (loss), net of tax, attributable to parent:(6,808)(8,785)(21,577)66,109(24,957)(25,034)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: